Innoviva
INVA
208 hedge funds and large institutions have $1.18B invested in Innoviva in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 10 closing their positions.
250% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 10
168% more call options, than puts
Call options by funds: $7.34M | Put options by funds: $2.74M
32.63% more ownership
Funds ownership: 69.06% → 101.69% (+33%)
26% more capital invested
Capital invested by funds: $939M → $1.18B (+$241M)
12% more funds holding
Funds holding: 185 → 208 (+23)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 73
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$10.8M |
| 2 |
Millennium Management
New York
|
+$8.97M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$6.38M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$6.04M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$26.8M |
| 2 |
BlackRock
New York
|
-$18.5M |
| 3 |
Renaissance Technologies
New York
|
-$6.48M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.96M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.7M |
INVA Hedge Fund Activity: Q3 2021 in Review
208 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2021, worth a combined $1.18B — up 26% from $939M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new INVA positions and 10 closed out — a net gain of 25 holders — while 68 added to existing stakes and 73 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $10.8M. The largest seller was Invesco, cutting an estimated $26.8M.
- 208 institutional investors held Innoviva (INVA) as of Q3 2021, up from 185 in Q2 2021.
- Funds reported $1.18B of Innoviva stock for Q3 2021, up 26% quarter-over-quarter.
- 35 funds opened new Innoviva positions in Q3 2021 and 10 closed out, a net change of +25 holders.
- The largest Innoviva buyer in Q3 2021 was Arrowstreet Capital, an estimated $10.8M added.
- The largest Innoviva seller in Q3 2021 was Invesco, an estimated $26.8M sold.
Based on aggregated 13F filings for Q3 2021.